Company Filing History:
Years Active: 2012
Title: Hiroshi Uchino: Innovator in Insulin Infusion Therapy
Introduction
Hiroshi Uchino is a prominent inventor based in Bunkyo-ku, Japan. He has made significant contributions to the field of medical technology, particularly in diabetes management. His innovative work focuses on optimizing insulin delivery for patients requiring continuous subcutaneous insulin infusion therapy.
Latest Patents
Hiroshi Uchino holds a patent for a mechanism that enhances the insulin infusion rate of a continuous subcutaneous insulin infusion (CSII) pump tailored to individual patients. The patent, titled "Continuous subcutaneous insulin infusion therapy," outlines a method that includes determining a circadian variation curve representing sympathetic and parasympathetic nerve activity of the target patient. It involves acquiring inflection points of these curves, detecting corresponding times, and adjusting the insulin infusion rate accordingly. This innovation aims to improve the effectiveness of insulin therapy for diabetic patients.
Career Highlights
Uchino is affiliated with Juntendo University, where he continues to advance research in medical technologies. His work has garnered attention for its potential to significantly improve patient outcomes in diabetes care. With a focus on personalized medicine, Uchino's contributions are paving the way for more effective treatment options.
Collaborations
Hiroshi Uchino collaborates with esteemed colleagues, including Yasushi Tanaka and Ryuzo Kawamori. Their combined expertise enhances the research and development of innovative solutions in the medical field.
Conclusion
Hiroshi Uchino's work in continuous subcutaneous insulin infusion therapy exemplifies the impact of innovation in healthcare. His patent and ongoing research contribute to the advancement of diabetes management, ultimately improving the quality of life for patients.